Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief

Dane D. Jensen(Australian Research Council), Nigel W. Bunnett(University of California, San Francisco), Carmen Klein Herenbrink(Australian Research Council), TinaMarie Lieu(Australian Regenerative Medicine Institute), Daniel P. Poole(Monash University), Michelle L. Halls(Discovery Institute), Nicholas A. Veldhuis(Australian Research Council), Adam McCluskey(University of Newcastle Australia), MacDonald J. Christie(The University of Sydney), Christopher J. H. Porter(Monash University), Jamie S. Simpson(University of Michigan), Joshua Conner(Australian Research Council), M.J. Scanlon(Monash University), Νicholas Barlow(Monash University), Meritxell Canals(University of Nottingham), Romina Nassini(University of Florence), Wendy L. Imlach(Discovery Institute), Tim Quach(Australian Research Council), Serena Materazzi(University of Florence), Gareth A. Hicks(Takeda (Japan)), Virginie Escriou(Centre National de la Recherche Scientifique), Luigi Aurelio(Australian Research Council), Pierangelo Geppetti(University of Ferrara), Bimbil Graham(Monash University), Phillip J. Robinson(Canterbury Christ Church University)
Science Translational Medicine
May 31, 2017
Cited by 240


Related Papers